Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-1272]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTARY INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before November 28, 2023. Such persons may also file a written request for a hearing on the application on or before November 28, 2023.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on June 21, 2023, Restek Corporation, 110 Benner Circle, Bellefonte, Pennsylvania 16823-8433, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleGamma Hydroxybutyric Acid
2010
IMethaqualone
2565
IJWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole)
7118
IJWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole)
7200
ICP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol)
7297
ICP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol)
7298
ILysergic acid diethylamide
7315
IMarihuana
7360
ITetrahydrocannabinols
7370
I4-Methyl-2,5-dimethoxyamphetamine
7395
I3,4-Methylenedioxyamphetamine
7400
I3,4-Methylenedioxy-N-ethylamphetamine
7404
I3,4-Methylenedioxymethamphetamine
7405
IBufotenine
7433
IPsilocybin
7437
IPsilocyn
7438
ICyprenorphine
9054
IDihydromorphine
9145
IHeroin
9200
INormorphine
9313
IBeta-hydroxyfentanyl
9830
IBeta-hydroxy-3-methylfentanyl
9831
I
 
 
 The company plans to bulk manufacture the listed controlled substances for DEA exempted certified reference materials. In-house synthesis gives access to compounds that are difficult to source. No other activities for these drug codes are authorized for this registration. Claude Redd, Acting Deputy Assistant Administrator.


[FR Doc. 2023-21401 Filed 9-28-23; 8:45 am] BILLING CODE P